Jürgen Steffgen

1PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 19, 2025
Two-year treatment experience with BI 655064, an antagonistic anti-CD40 antibody, in patients with active lupus nephritis: An exploratory, phase II maintenance trial.

Richard Furie, Jürgen Steffgen, Nora Fagan

Pageof 1

Frequent Collaborators

1 joint publications

Yingyos Avihingsanon